Business · 14/07/2009
FDA Releases Guidance on Reporting Adverse Events for Nonprescription Human Drugs
The Food and Drug Administration (FDA) has published a guidance document outlining the requirements for reporting postmarketing serious adverse events for nonprescription human drugs that were marketed without prior FDA approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →